Drug helps MS patients with mobility problems

"At $1,000 a month this may be an obstacle in getting insurance companies to approve it. I like that there's a video along with this article showing someone who's been on it for the past 6 years (through the clinical trials) walking better."

Trouble walking is one of the biggest challenges faced by people with the neurological disease multiple sclerosis.

The Food and Drug Administration recently approved an oral medication to help people improve their walking speed - an encouraging development in the MS community.

To read the rest of the article and see the video on abclocal.go.com click here.